Frontlight ResearchEarly access
Liver and biliary tract cancer trials in Taiwan
54 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab
- Where
- Tainan, Taipei, Taoyuan
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07391670 · EU 2025-521639-34-00 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Liou Ying Township, Taipei, Taoyuan
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - Phase 1Taking peopleA Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
- Where
- Taipei
- Age
- 18 years and over
- People
- 232 worldwide
- Run by
- AbbVie
See details and how to joinNCT06858813 · EU 2024-518012-39-00 - Phase 1/2Taking peopleGPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
- Where
- Taipei
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- Eureka Therapeutics Inc.
See details and how to joinNCT04864054 - Phase 2Taking peopleEfficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
- Where
- Hualien City, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
- Age
- 20 years and over
- People
- 95
- Run by
- Lukas Biomedical Inc.
See details and how to joinNCT05304481 - Phase 1/2Active, not recruitingA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Where
- Changhua, Kaohsiung City, Taipei
- Age
- 18 years and over
- People
- 796 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05150691 - No phaseTaking peopleDevelopment and Dissemination of Exercise Prescription and Intervention for Cancer Populations
- Where
- Kaohsiung
- Age
- 18 years to 80 years
- People
- 150
- Run by
- Kaohsiung Medical University Chung-Ho Memorial Hospital
See details and how to joinNCT07751783 - Phase 1/2Taking peopleTo Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization
- Where
- Taipei, Taoyuan
- Age
- 18 years to 85 years
- People
- 120
- Run by
- Febico Biomedical Corp.
See details and how to joinNCT06478719 - No phaseNot yet taking people in TaiwanHCC Risk and Monitoring in Patients With Type 2 Diabetes
- Where
- Taipei
- Age
- 18 years and over
- People
- 2,400
- Run by
- National Taiwan University Hospital
See details and how to joinNCT07675187 - Phase 1/2Taking peopleA Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Where
- Tainan, Taipei, Taoyuan
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00 - Phase 2Taking peopleSHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin
- Where
- Taipei
- Age
- 18 years and over
- People
- 39
- Run by
- National Taiwan University Hospital
See details and how to joinNCT07560566 - Phase 2Taking peopleCVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma
- Where
- Kaohsiung City, Keelung, Tainan, Taipei
- Age
- 18 years and over
- People
- 95
- Run by
- TaiRx, Inc.
See details and how to joinNCT05257590 - Phase 1CompletedA Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
- Where
- Tainan, Taipei
- Age
- 18 years to 75 years
- People
- 200 worldwide
- Run by
- Abbisko Therapeutics Co, Ltd
See details and how to joinNCT04906434 - Phase 2Taking peopleAtezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma
- Where
- Taoyuan City
- Age
- 18 years and over
- People
- 45
- Run by
- Chang Gung Memorial Hospital
See details and how to joinNCT06133062 - No phaseTaking peopleFeasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room
- Where
- Taipei
- Age
- 18 years and over
- People
- 315
- Run by
- Taipei Veterans General Hospital, Taiwan
See details and how to joinNCT07473687 - Phase 3Taking peopleStudy of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma
- Where
- Changhua, Chiayi City, Kaohsiung City, Tainan, Taoyuan
- Age
- 18 years to 99 years
- People
- 300 worldwide
- Run by
- Polaris Group
See details and how to joinNCT05317819 - Phase 1Taking peopleA Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
- Where
- Taipei
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- Myeloid Therapeutics
See details and how to joinNCT06478693 - Phase 1/2Taking peoplePhase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients
- Where
- Tainan
- Age
- 18 years and over
- People
- 42
- Run by
- Medigen Biotechnology Corporation
See details and how to joinNCT06730009 - Phase 2Taking peopleHepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma
- Where
- Taipei
- Age
- 20 years and over
- People
- 24
- Run by
- National Taiwan University Hospital
See details and how to joinNCT06632717 - No phaseTaking peopleLiver Disease and Other Systemic Diseases
- Where
- New Taipei City
- Age
- 18 years to 99 years
- People
- 15,000
- Run by
- Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
See details and how to joinNCT04525833 - Phase 2Not yet taking people in TaiwanCabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy
- Where
- Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
- Age
- 18 years and over
- People
- 60
- Run by
- National Health Research Institutes, Taiwan
See details and how to joinNCT07151326 - No phaseNot yet taking people in TaiwanAHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy
- Where
- Tainan
- Age
- 20 years and over
- People
- 94
- Run by
- National Cheng-Kung University Hospital
See details and how to joinNCT07118735 - Phase 2Not yet taking people in TaiwanNeoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma
- Where
- Tainan
- Age
- 18 years and over
- People
- 35
- Run by
- National Cheng-Kung University Hospital
See details and how to joinNCT06903273 - Phase 1Taking peopleA Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
- Where
- Taichung, Tainan
- Age
- 18 years and over
- People
- 24
- Run by
- LaunXP Biomedical Co., Ltd.
See details and how to joinNCT06883539 - Phase 4Taking peopleEndoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC
- Where
- Taipei
- Age
- 20 years to 90 years
- People
- 120
- Run by
- Taipei Veterans General Hospital, Taiwan
See details and how to joinNCT06594744